In summary, we found STEAP4 was low in HCC cells and tissues, patients with low STEAP4 had poor prognosis, and it is an independent prognostic factor for HCC patients and inhibited HCC chemotherapy resistance through suppressing PI3K/AKT pathway. Here, AKT1 is linked to hepatocellular carcinoma.